Restart Life Sciences NMLSF Stock
Restart Life Sciences Price Chart
Restart Life Sciences NMLSF Financial and Trading Overview
| Restart Life Sciences stock price | 0.05 USD |
| Previous Close | 0.06 USD |
| Open | 0.05 USD |
| Bid | 0.05 USD x 3000000 |
| Ask | 0.07 USD x 2000000 |
| Day's Range | 0.05 - 0.05 USD |
| 52 Week Range | 0.01 - 0.12 USD |
| Volume | 24 USD |
| Avg. Volume | 1.46K USD |
| Market Cap | 3.92M USD |
| Beta (5Y Monthly) | -0.755 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NMLSF Valuation Measures
| Enterprise Value | 3M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 29.09907 |
| Price/Book (mrq) | 3.3568242 |
| Enterprise Value/Revenue | 22.293 |
| Enterprise Value/EBITDA | -3.186 |
Trading Information
Restart Life Sciences Stock Price History
| Beta (5Y Monthly) | -0.755 |
| 52-Week Change | -5.0075% |
| S&P500 52-Week Change | 18.35% |
| 52 Week High | 0.12 USD |
| 52 Week Low | 0.01 USD |
| 50-Day Moving Average | 0.06 USD |
| 200-Day Moving Average | 0.07 USD |
NMLSF Share Statistics
| Avg. Volume (3 month) | 1.46K USD |
| Avg. Daily Volume (10-Days) | 326 USD |
| Shares Outstanding | 62.36M |
| Float | 55.91M |
| Short Ratio | N/A |
| % Held by Insiders | 6.55% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:2 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -231.055% |
| Gross Margin | 46.03% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -43.74% |
| Return on Equity (ttm) | -99.24% |
Income Statement
| Revenue (ttm) | 134.55K USD |
| Revenue Per Share (ttm) | 0.003 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 61.94K USD |
| EBITDA | -941516 USD |
| Net Income Avi to Common (ttm) | -897928 USD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.19M USD |
| Total Cash Per Share (mrq) | 0.02 USD |
| Total Debt (mrq) | 354.09K USD |
| Total Debt/Equity (mrq) | 22.94 USD |
| Current Ratio (mrq) | 2.006 |
| Book Value Per Share (mrq) | 0.01870518 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -556037 USD |
| Levered Free Cash Flow (ttm) | -489605 USD |
Profile of Restart Life Sciences
| Country | United States |
| State | BC |
| City | Vancouver |
| Address | 700-838 West Hasting Street |
| ZIP | V6C 0A6 |
| Phone | 778 819 0244 |
| Website | https://www.restartlife.co |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company in Canada. It engages in research and development of psilocybin; and fund food-related research initiative in support of its expanding portfolio of consumer health and wellness products. The company has collaboration with the University of Manitoba's Richardson Centre for food technology and research (RCFTR) to support a series of food-related scientific studies, including the development across various product lines, including BrainQ, BrainBalls, and Holy Crap. The company was formerly known as Nova Mentis Life Science Corp. and changed its name to Restart Life Sciences Corp. in November 2024. Restart Life Sciences Corp. was incorporated in 2004 and is based in Vancouver, Canada.
Q&A For Restart Life Sciences Stock
What is a current NMLSF stock price?
Restart Life Sciences NMLSF stock price today per share is 0.05 USD.
How to purchase Restart Life Sciences stock?
You can buy NMLSF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Restart Life Sciences?
The stock symbol or ticker of Restart Life Sciences is NMLSF.
Which industry does the Restart Life Sciences company belong to?
The Restart Life Sciences industry is Biotechnology.
How many shares does Restart Life Sciences have in circulation?
The max supply of Restart Life Sciences shares is 62.36M.
What is Restart Life Sciences Price to Earnings Ratio (PE Ratio)?
Restart Life Sciences PE Ratio is now.
What was Restart Life Sciences earnings per share over the trailing 12 months (TTM)?
Restart Life Sciences EPS is -0.01 USD over the trailing 12 months.
Which sector does the Restart Life Sciences company belong to?
The Restart Life Sciences sector is Healthcare.
